Clinical trial Recruiting at 1 site Interventional Ages 40 to 70

Tracking glucose tolerance in patients with type 2 diabetes using technology

Official title: A Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 Diabetes

Run by University of Pavia · NCT06864546 · Data updated 2026-11-12

This study is testing if using continuous glucose monitors and health tracking devices can help people with type 2 diabetes who aren't on insulin make better lifestyle choices to manage their blood sugar levels.

Quick facts

Study typeInterventional
Ages40 Years to 70 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Pavia
Academic / other
Locations1 site (Pavia, Pavia)
StatusRecruiting
StartedMay 2025
Main results expectedDecember 2025
Study endsJanuary 15, 2026
Registry record updatedApril 30, 2025
Trial IDNCT06864546 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are sedentary individuals aged 40 to 70 with non-insulin treated type 2 diabetes.

Probably not a fit

Patients who have been diagnosed with diabetes for less than three years or those with significant heart disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the management of type 2 diabetes through a participatory e-health approach that utilizes continuous glucose monitors (CGM) and other health tracking devices. By collecting real-time health data from patients, the study will develop an easy-to-use tool for tracking metabolic status and analyze the relationship between lifestyle changes and glucose levels. The focus is on sedentary individuals with type 2 diabetes who are not on insulin treatment, promoting lifestyle interventions to improve their health outcomes.

Why it matters

Potential benefit: If successful, this approach could empower patients to better manage their diabetes and potentially reverse their condition through lifestyle changes.

How similar studies have gone: While many studies have shown success with CGM devices in type 1 diabetes and advanced type 2 diabetes, this approach in non-insulin treated type 2 diabetes is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Non-insulin treated T2D diagnosis (not treated at all or only with metformin);
* Physically inactive (less than 150 minutes/week of moderate physical activity);
* Age between 40 and 70;
* HbA1c below 8.5%.

Exclusion Criteria:

* Diabetes diagnosis less than 3 years before the study initiation;
* Pregnancy;
* Symptomatic heart disease, e.g. history of myocardial infarction, coronary bypass, stenting procedure, angina, or any ischemic cerebrovascular event;
* Use of a medication that significantly impacts glucose metabolism (oral steroids);
* Use of a medication that significantly lowers heart rate (beta blockers, reserpine, guanethidine, methyldopa, clonidine, cimetidine, digitalis, calcium channel blockers, amiodarone, antiarrhythmic drugs, or lithium);
* Atrial fibrillation;
* Use of an electronic pacemaker.

Where it's running

  • Istituti Clinici Scientifici Maugeri di Pavia
    Pavia, Pavia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.